A Phase 3 trial evaluating the efficacy, duration of effect, and safety of DaxibotulinumtoxinA for Injection in the treatment of cervical dystonia

被引:0
|
作者
Jankovic, J.
Comella, C.
Hauser, R.
Patel, A.
Gross, T.
Rubio, R.
Vitarella, D.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
100
引用
收藏
页码:S43 / S44
页数:2
相关论文
共 50 条
  • [1] A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia
    Jankovic, Joseph
    Comella, Cynthia
    Hauser, Robert A.
    Patel, Atul T.
    Gross, Todd M.
    Rubio, Roman G.
    Vitarella, Domenico
    TOXICON, 2022, 214 : S27 - S27
  • [2] A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia
    Jankovic, Joseph
    Comella, Cynthia
    Hauser, Robert A.
    Patel, Atul T.
    Gross, Todd M.
    Rubio, Roman G.
    Vitarella, Domenico
    NEUROLOGY, 2021, 96 (15)
  • [3] A PHASE 3 TRIAL EVALUATING THE EFFICACY, DURATION OF EFFECT, AND SAFETY OF DAXIBOTULINUMTOXINA FOR INJECTION IN THE TREATMENT OF CERVICAL DYSTONI
    Jankovic, Joseph
    Comella, Cynthia
    Hauser, Robert A.
    Patel, Atul T.
    Gross, Todd M.
    Rubio, Roman G.
    Vitarella, Domenico
    TOXICON, 2021, 190 : S34 - S35
  • [4] Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial
    Comella, Cynthia L.
    Jankovic, Joseph
    Hauser, Robert A.
    Patel, Atul T.
    Banach, Marta D.
    Ehler, Edvard
    Vitarella, Domenico
    Rubio, Roman G.
    Gross, Todd M.
    NEUROLOGY, 2024, 102 (04) : e208091
  • [5] A Phase 3, Open-Label, Multicenter Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia
    Slawek, Jaroslaw
    McAllister, Peter
    Paus, Sebastian
    Truong, Daniel
    Gross, Todd M.
    Rubio, Roman G.
    Kesslak, Pat
    Vitarella, Domenico
    TOXICON, 2022, 214 : S50 - S50
  • [6] SAFETY AND EFFICACY OF DAXIBOTULINUMTOXINA FOR INJECTION (RT002) IN CERVICAL DYSTONIA (CD): RESULTS OF A PHASE 2, DOSE ESCALATING STUDY
    Truong, D.
    Comella, C.
    Jankovic, J.
    Brashear, A.
    Patel, A. T.
    Evatt, M.
    Oh, C.
    Snyder, D.
    Rubio, R. G.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E27 - E27
  • [7] Efficacy and Safety of DaxibotulinumtoxinA for Injection Over Successive Treatments in Adults With Cervical Dystonia in the Phase 3 ASPEN-1 and ASPEN-OLS Trials
    Comella, Cynthia
    Barbano, Richard
    Singer, Carlos
    Vasquez, Alberto
    Gross, Todd M.
    Vitarella, Domenico
    TOXICON, 2024, 237 : 19 - 19
  • [8] Efficacy and Safety of DaxibotulinumtoxinA for Injection Over Successive Treatments in Adults With Cervical Dystonia in the Phase 3 ASPEN-1 and ASPEN-OLS Trials
    Comella, Cynthia
    Barbano, Richard
    Singer, Carlos
    Vasquez, Alberto
    Gross, Todd
    Rubio, Roman
    Kooken, Kristie
    Vitarella, Domenico
    NEUROLOGY, 2023, 100 (17)
  • [9] Long-term Safety of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia in Phase 3, Open-label, Multicenter ASPEN-OLS Trial
    McAllister, Peter
    Jinnah, H.
    Evidente, Virgilio Gerald
    Patel, Atul
    Gross, Todd
    Rubio, Roman
    Vitarella, Domenico
    NEUROLOGY, 2023, 100 (17)
  • [10] Long-Term Safety of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia in Phase 3, Open-label, Multicenter ASPEN-OLS Trial
    McAllister, Peter
    Jinnah, H. A.
    Evidente, Virgilio
    Patel, Atul T.
    Gross, Todd M.
    Vitarella, Domenico
    TOXICON, 2024, 237 : 59 - 59